Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possibl
| Image |  |
|---|---|
| Description | scientific article published on 04 August 2020 |
| Author/s |
author: Hendrik Schulze-Koops Rebecca Hasseli |
| Publication date | August 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |